Unknown

Dataset Information

0

Adverse Events in Treating Smear-Positive Tuberculosis Patients in China.


ABSTRACT: This study aimed to estimate the adverse events (AE) rate during anti-tuberculosis treatment and to explore AE-related risk factors. New and previously treated smear-positive tuberculosis (TB) cases were enrolled from eight regions in China between April 2009 and October 2010. The AE rate was estimated, and AE risk factors during anti-TB treatment were assessed using Cox proportional models. Among 2091 Chinese subjects with anti-TB treatment, 462 (22.1%, 95% confidence interval (CI), 20.3-23.9) patients developed AE, with liver injury and gastrointestinal reactions constituting the most common AE. Specifically, 9.8% (95% CI, 8.5-11.1) and 6.3% (95% CI, 5.3-7.4) developed liver injuries and gastrointestinal reactions, respectively. We found that AE rate differed by regions, TB knowledge score, symptoms score and smoking status. Liver injuries were associated with age, sex and smoking status; gastrointestinal reactions were associated with education level and symptom score. Improving patients' knowledge on TB could reduce AE rate.

SUBMITTER: Zhang T 

PROVIDER: S-EPMC4730477 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adverse Events in Treating Smear-Positive Tuberculosis Patients in China.

Zhang Tao T   Du Jian J   Yin Xiaoyan X   Xue Fuzhong F   Liu Yanxun Y   Li Runzi R   Luo Cheng C   Li Liang L   Li Xiujun X  

International journal of environmental research and public health 20151229 1


This study aimed to estimate the adverse events (AE) rate during anti-tuberculosis treatment and to explore AE-related risk factors. New and previously treated smear-positive tuberculosis (TB) cases were enrolled from eight regions in China between April 2009 and October 2010. The AE rate was estimated, and AE risk factors during anti-TB treatment were assessed using Cox proportional models. Among 2091 Chinese subjects with anti-TB treatment, 462 (22.1%, 95% confidence interval (CI), 20.3-23.9)  ...[more]

Similar Datasets

| S-EPMC2916303 | biostudies-literature
| S-EPMC3707095 | biostudies-literature
| S-EPMC8033743 | biostudies-literature
| S-EPMC2650956 | biostudies-literature
| S-EPMC4451210 | biostudies-literature
| S-EPMC3665834 | biostudies-other
| S-EPMC6838572 | biostudies-literature
| S-EPMC5650427 | biostudies-literature
| S-EPMC5366362 | biostudies-other
| S-EPMC6125223 | biostudies-literature